PRINCETON, NJ, Diligent Pharma announced the closing of an $8.27 Million Series A financing round led by FCA Venture Partners.
Diligent Pharma Inc, a private vendor qualification and risk management organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution, announced the closing of an $8.27 Million Series A financing round led by FCA Venture Partners. Additional investors include PJC, and GenHenn Capital along with private investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
